Inhibition of glutaminolysis by targeting GLS1 or GLS2, for example, reduces LC and hepatocellular carcinoma (HCC) metastases, respectively, through repression of SNAIL [202]. The gene discussed is GLS2; the disease is laryngotracheoesophageal cleft.